Sharechat Logo

General Capital Limited (GEN) Migrates to the NZX Main Board

Monday 1st July 2019

Text too small?

General Capital today migrated to the main board of the NZX. 

This follows other key milestones achieved for the Group, including:

1.  The completion of the purchase of an operating Group of financial services businesses in August 2018. This included the businesses of:

         a)  General Finance Limited (Licenced Non-bank Deposit Taker); and
         b)  Investment Research Group Limited (NZX Sponsor / Investment Research                   House / Investment Banking firm).

2.  The rebranding of the Group to General Capital Limited (from previous listed shell, Mykco Limited).

3.  The raising of new capital by way of placements and shareholder purchase plan in late 2018.

4.  Strong March 2019 results including year on year growth in the loan book of 101%, year on year growth in secured term deposit liabilities of 51%, and a trading profit achieved when excluding the costs of business acquisition.

Mr Brent King (Managing Director) said, “This has been an excellent 12 months for the Group, with growth continuing to be strong into the 2020 financial year”.

For further information contact:

Mr. Brent King 

Managing Director 

+64 21 632 660 

Brent.King@gencap.co.nz




  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 30th Morning Report
December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK